Johnson & Johnson Stock News

Pharmaceuticals giant Johnson & Johnson has halted production of its coronavirus medicine at its production site in Leiden, to focus

After Tuesdays jump in the number of deaths, the number of deaths reported on Wednesday is back to single digits. Nine deaths have brought the covid19 death toll to 3,495, including a young adult female. Another 756 covid19 cases were reported from samples taken between Friday and Tuesday. The number of active cases is now 21,629. The Health Ministrys covid19 update said the people who died were four elderly men, three elderly women, one middle-aged woman, and one young adult woman. It said four of these people had multiple comorbidities, including a mix of diabetes, hypertension, a history of strokes, obesity, heart disease, schizophrenia, and asthma. Four people each had only one comorbidity, and one person had no known medical condition. Since March 2020, there have been 117,525 cases of covid19, of which 93,035 have recovered. There are 352 patients in hospital. Of these, there are 83 people at the Couva Hospital and Multi-Training Facility, with 13 in the intensive care unit and five in the high dependency unit.

NEW BRUNSWICK, N.J. , Feb. 9, 2022 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will participate in the Raymond James 43rd Annual Institutional Investors Conference on Tuesday, March 8 th . Joseph J. Wolk, Executive Vice President and Chief Full story available on Benzinga.com

Specialty Pharmaceutical Market 2022 Covid 19 Impact on Top countries data Industry Trends, Share, Size, Demand, Growth Opportunities, Industry Revenue, Future and Business Analysis by Forecast New York, NY -- ( SBWIRE ) -- 02/09/2022 -- Specialty Pharmaceutical Market 2022-2028 A New Market Study, Titled "Specialty Pharmaceutical Market Upcoming Trends, Growth Drivers and Challenges" has been featured on fusionmarketresearch. Description This global study of the Specialty Pharmaceutical Market offers an overview of the existing market trends, drivers, restrictions, and metrics and also offers a viewpoint for important segments. The report also tracks product and services demand growth forecasts for the market. There is also to the study approach a detailed segmental review. A regional study of the global Specialty Pharmaceutical industry is also carried out in North America, Latin America, Asia-Pacific, Europe, and the Near East & Africa. The report mentions growth parameters in the regional markets along with major players dominating the regional growth.

Johnson & Johnson''s Covid-19 vaccine, initially billed as a single shot, fell out of favour in the US and other wealthy countries in part because of its link to a rare but dangerous blood-clotting disorder Read more

Gainers US Ecology, Inc. (NASDAQ: ECOL ) shares jumped 68.1% to $47.34 after Republic Services reported it will buy the company at $48 per share in cash. Tritium DCFC Limited (NASDAQ: DCFC ) gained 65.4% to $15.78. Tritium DCFC shares surged nearly 40% Tuesday after the Australian EV charging company announced its new manufacturing facility will be located in the United States. Tritium CEO Jane Hunter appeared at the White House to make the announcement yesterday. Infobird Co., Ltd (NASDAQ: IFBD ) gained 32.6% to $1.2393. Infobird recently signed a contract with subsidiary of Nippi Japan for digital marketing solutions. Doximity, Inc. (NYSE: DOCS ) shares gained 25.1% to $62.30 after the company reported better-than-expected Q3 results and issued FY22 sales guidance above estimates. Aptevo Therapeutics Inc. (NASDAQ: APVO ) jumped 20.5% to $7.29 after the company announced it has earned a $10 million non-dilutive milestone payment related to 2021 sales of RUXIENCE. Absolute Software Corporation (NASDAQ: ABST ) gained 17.9% to $9.47 after the company reported better-than-expected Q2 sales results and issued FY22 sales guidance.

DUBLIN--(BUSINESS WIRE)--The "Baby Wipes Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com''s offering. The global baby wipes market reached a value of US$ 4.60 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 5.65 Billion by 2027, exhibiting a CAGR of 3.3% during 2022-2027. Companies Mentioned Johnson & Johnson Procter & Gamble Kimberly-Clark Corporation Unicharm Corpora

.As WHO, CommonWealth Make Case for Poor Nations By Laide Akinboade, Abuja The European Union (EU) has donated additional two million more doses of Johnson and Johnson, (J&J), COVID-19 vaccines to Nigeria. The Executive Director of the National Primary Healthcare Development Agency, NPHCDA, Dr. Faisal Shuaib, took the delivery of the vaccines during the handover […] The post EU Donates 2m more Doses of Covid-19 Vaccine to Nigeria appeared first on Daily Asset Online .

Johnson & Johnson quietly halts the production of its Covid vaccine. JOHNSON & Johnson quietly halts production of its Covid vaccine, according to the New York Times. In fact, the company shut down the only plant making usable vaccine batches in Leiden, Netherland late last year. According to the NYT on Tuesday, February 8, J&J, [] The post Johnson & Johnson quietly halts production of Covid vaccine appeared first on Euro Weekly News Spain .

Johnson & Johnson has shut down the plant making batches of its vaccine, according to people familiar with the decision.

Reports that Johnson & Johnson, a critical supplier of Covid vaccines for the developing world, quietly shut down production at an overseas plant are fueling concerns that the coronavirus will continue to mutate. The company says it continues to “fulfill our contractual obligations” with those initiatives.

Johnson & Johnson has temporarily suspended production at a key plant manufacturing the COVID-19 vaccine, the New York Times reported Tuesday.

The company''s one-dose COVID-19 vaccine has been the only option in some parts of the world.

The drugmaker reportedly closed the Dutch plant that was making the vaccine to focus on a different drug.

Johnson & Johnson has halted production of its only single shot covid vaccine as the only facility producing batches focuses on making a new vaccine.